Dr. James W. Marsh

Abhinav Humar, MD, is the clinical director of the Thomas E. Starzl Transplantation Institute and chief of UPMC Transplant Services. He received his medical degree from the University of Ottawa where he also completed his general surgical residency. He completed his surgical fellowship in transplantation at the University of Minnesota. Dr. Humar is a member of the American Society of Transplant Surgeons and the International Liver Transplantation Society with more than 600 abstracts accepted at national and international transplant meetings and has co-authored more than 200 manuscripts, 30 book chapters and two books. Dr. Humar’s clinical interests include living donor and split liver transplants and studies of hepatic regeneration. View Dr. Humar’s full list of publications from PubMed. Dr. Humar is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Liver Failure, Fibrolamellar Carcinoma, Liver Cancer, Liver Transplant, and Kidney Transplant.

Michele Molinari is a Transplant Surgeon in Pittsburgh, Pennsylvania. Dr. Molinari is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Liver Failure, Liver Cancer, Pancreatic Cancer, Liver Transplant, and Kidney Transplant. Dr. Molinari is currently accepting new patients.

Amit Tevar, MD, is the surgical director of the Kidney and Pancreas Transplant Program at UPMC and is certified in multi-organ transplantation and hepatobiliary by the American Board of Surgery. Dr. Tevar received his medical degree from the University of Missouri School of Medicine and completed his residency in general surgery at Indiana University School of Medicine where he served as chief resident. He completed his fellowship in multi-organ transplant surgery at the University of Chicago and the University of Cincinnati. Dr. Tevar is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Liver Failure, Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Kidney Transplant, and Liver Transplant.